
C10H11N2⁺ · 159.21 g/mol
10 in stock01 / Metabolism
5-Amino-1MQ 10mg
5-Amino-1MQ 10mg — NNMT inhibitor and NAD+ preservation research standard.

Live specimen · crystalline phase
Cellular architect / 2026
Precision-synthesized peptide reference materials, documented with uncompromising molecular transparency.
Compound library

C10H11N2⁺ · 159.21 g/mol
10 in stock01 / Metabolism
5-Amino-1MQ 10mg — NNMT inhibitor and NAD+ preservation research standard.

C11H15N2O5P · ~274.18 Da
11 in stock02 / Longevity
5-amino-1MQ is an investigational NAD+ modulator studied for its potential influence on cellular energy metabolism and longevity pathways in laboratory research environments.

C₃₂H₆₀N₁₂O₈Cu · 820.43 g/mol
16 in stock03 / Aesthetic
Copper-binding tripeptide studied for hair follicle stimulation, collagen synthesis, and skin rejuvenation.

C₁₅₅H₂₆₇N₄₇O₄₈S₂ · ~3,476 Da
14 in stock04 / Recovery
Synthetic erythropoietin derivative peptide investigated for tissue-protective, anti-inflammatory, and neuroprotective activity.

H2O + 0.9% benzyl alcohol · 18.02 g/mol
64 in stock05 / Supplies
Bacteriostatic water 10cc — reconstitution solvent for peptide research preparation.

H2O + 0.9% benzyl alcohol · 18.02 g/mol
60 in stock06 / Supplies
Bacteriostatic water 3cc — reconstitution solvent for peptide research preparation.

C₆₂H₉₈N₁₆O₂₂ · 1419.55 g/mol
20 in stock07 / Recovery
Gastric-derived pentadecapeptide studied for gastroprotection, tendon and ligament healing.

C₅₀H₆₈N₁₄O₁₀ · 1025.16 g/mol
18 in stock08 / Aesthetic
Melanocortin receptor agonist investigated for sexual wellness and arousal support.

C32H49N9O6S2 · 711.94 g/mol
40 in stock09 / Longevity
Elamipretide (SS-31) 10mg — mitochondrial-targeting peptide for cardiolipin research.

C14H24N6O4·Cu · 403.92 g/mol
6 in stock010 / Aesthetic
GHK-Cu copper peptide 50mg — tissue remodeling and dermal research standard.

Dermal peptide composite · Variable blend
20 in stock011 / Aesthetic
Aesthetic peptide blend for dermal matrix and tissue remodeling research.

Multi-peptide composite · Variable blend
19 in stock012 / Recovery
High-potency multi-peptide recovery stack for advanced tissue-response protocols.

Cognitive peptide blend · Variable blend
20 in stock013 / Cognition
Neurotrophic cognitive peptide blend for cognitive-pathway research environments.

C19H34N4O4 · 382.5 g/mol
16 in stock014 / Recovery
KPV (Lys-Pro-Val) 10mg — anti-inflammatory peptide for mucosal and tissue research.

C102H164N28O33S2 · 2188.7 g/mol
20 in stock015 / Longevity
MOTS-c 10mg — mitochondria-derived peptide for metabolic aging research.

C102H164N28O33S2 · 2188.7 g/mol
20 in stock016 / Longevity
MOTS-c 20mg — mitochondria-derived peptide for metabolic aging research.

C21H27N7O14P2 · 663.43 g/mol
11 in stock017 / Longevity
NAD+ 100mg — nicotinamide adenine dinucleotide coenzyme research standard.

C240H386N52O66 · 4776.2 g/mol
20 in stock018 / Metabolism
Retatrutide 10mg — triple GIP/GLP-1/glucagon receptor agonist research standard.

C240H386N52O66 · 4776.2 g/mol
5 in stock019 / Metabolism
Retatrutide 20mg — triple GIP/GLP-1/glucagon receptor agonist research standard.

C187H291N45O59 · 4113.58 g/mol
20 in stock020 / Metabolism
Semaglutide 10mg — GLP-1 receptor agonist for metabolic pathway research.

C187H291N45O59 · 4113.58 g/mol
20 in stock021 / Metabolism
Semaglutide 20mg — GLP-1 receptor agonist for metabolic pathway research.

C₃₇H₅₁N₉O₁₂S · 813.91 g/mol
23 in stock022 / Cognition
ACTH-derived heptapeptide studied for cognitive enhancement, neuroprotection, and attention.

C₃₇H₅₁N₉O₁₂S · 813.91 g/mol
17 in stock023 / Cognition
ACTH-derived heptapeptide formulated as a saline-based nasal spray studied for cognitive enhancement, neuroprotection, and attention.

C₄₁H₇₀N₁₆O₁₀ · 935.10 g/mol
19 in stock024 / Aesthetic
Octapeptide neurotransmitter-release inhibitor studied for its wrinkle-reducing and anti-aging dermatological activity.

C157H253N51O44S2 · ~3,479 Da
13 in stock025 / Metabolism
Growth hormone-releasing hormone (GHRH) analog investigated for visceral adipose tissue regulation in metabolic research environments.

C₂₁₅H₃₄₅N₅₇O₈₈S₁ · 4963.44 g/mol
20 in stock026 / Recovery
Synthetic analog of thymosin beta-4 involved in tissue repair, wound healing, and cellular regeneration.

C225H348N56O68 · 4813.52 g/mol
16 in stock027 / Metabolism
Tirzepatide 10mg — dual GIP/GLP-1 receptor agonist research standard.

C225H348N56O68 · 4813.52 g/mol
20 in stock028 / Metabolism
Tirzepatide 20mg — dual GIP/GLP-1 receptor agonist research standard.

C225H348N56O68 · 4813.52 g/mol
15 in stock029 / Metabolism
Tirzepatide 30mg — dual GIP/GLP-1 receptor agonist research standard.

C₂₂₅H₃₄₈N₆₀O₆₈ · ~4,844 Da
12 in stock030 / Metabolism
Dual GIP/GLP-1 receptor agonist investigated for glycemic control and weight management in metabolic research.

BPC-157 / TB-500 blend · 1419.56 / 4186.4 g/mol
17 in stock031 / Recovery
BPC-157 + TB-500 synergistic blend 20mg — tissue response research compound.

BPC-157: C62H98N16O22 · TB-500: C212H346N56O68S · BPC-157 1419.55 / TB-500 2113.40 g/mol
Sold out032 / Recovery
Wolverine 10mg — BPC-157 + TB-500 tissue-recovery peptide blend research standard.
Curated stacks
Pre-configured compound stacks for targeted research outcomes — bundled at a savings.
A curated stack of recovery compounds for tissue repair and post-exertion recuperation research.
• Body Protection Compound 157 (BPC-157) 10mg
• Thymosin Beta 4 (TB-500) 10mg
• Wolverine (BPC 157 5mg, Tb500 5mg) 10mg
Cognitive enhancement specimens targeting neurotransmitter pathways and synaptic plasticity.
• Semax 10mg Nasal Spray (Saline)
• Semax 10mg
• Klow (Cognitive Blend)
Independent HPLC and mass spectrometry verification.
Every specimen is mapped to a documented synthesis lot.
Controlled handling from synthesis through dispatch.